The available studies provide positive signals that vitamin C serums can help with pigmentation spots, but the evidence is not yet strong enough to recommend vitamin C as a standalone treatment. It has always been studied in combination with other substances or without a comparison group. For melasma, a combination serum containing niacinamide and tranexamic acid has the strongest support; for general skin ageing, a well-controlled study is almost entirely lacking.
Vitamin C serums have been used for years to address pigmentation spots and skin ageing, and there is some evidence that they can help. However, most available studies are small, lack a placebo group, or always investigate vitamin C in combination with other substances. This makes it difficult to say how much the vitamin C serum itself is responsible for.
For melasma (a form of chronic pigmentation), the most concrete results were found with a combination serum that, in addition to a low dose of vitamin C (0.2%), also contained niacinamide, tranexamic acid and hydroxy acids. That serum was as effective as the classic bleaching agent 4% hydroquinone, but was better tolerated: less redness and an improved skin barrier. However, it is not possible to isolate the contribution of vitamin C from the other active substances in that product. On the basis of this study alone, vitamin C cannot be given sole credit.
Microneedling in combination with topical agents, including vitamin C serum, reduced melasma significantly better than topical agents alone. That is a positive signal for the combination approach. A small supplementary study (30 patients) compared microneedling with vitamin C serum directly against microneedling with tranexamic acid and found no statistically significant difference after 6 weeks: both worked comparably well. However, that study was not randomised and was too small to draw firm conclusions from.
For anti-ageing effects, the evidence is thinner. An open-label study in 32 women showed improvement in fine lines, wrinkles and uneven skin tone after 12 weeks with an antioxidant serum combining vitamin C, astaxanthin, fermented turmeric and vitamin E. All participants showed improvement, but there was no control group: the placebo effect and sun protection may have played a role. Another study in 43 people with sensitive skin showed improvement in dark spots with a complete skincare regime including vitamin C serum and an SPF day cream, but here too it is impossible to determine which step made the difference.
There is also a biological basis for interest in vitamin C: melasma patients were found to have lower blood vitamin C levels and higher oxidative stress than people without melasma. This is consistent with the idea that vitamin C, as an antioxidant, may be relevant in pigment formation, but it is an observational association, not proof that a serum applied to the skin helps.
Finally, a safety note: people with haemochromatosis (a hereditary iron storage disorder) are explicitly warned in clinical guidelines to avoid additional vitamin C (as a supplement), because it accelerates iron absorption. The available source refers to oral intake; for topical serums this risk has not been described in the literature reviewed, but anyone with this condition would be wise to discuss it with a doctor.
All claims are based on 8 studies (PMID 40062688, 33857549, 35466647, 37608511, 37461812, 39630676, 29480422, 9867745). None of the studies investigates vitamin C as a standalone topical agent in a controlled RCT. Multiple studies have no control group. The only study with an active comparator (hydroquinone) used a low-dose combination serum.